A Food and Drug Administration Public Health Advisory was issued Jan. 17 warning that over-the-counter cough and cold products should not be used to treat infants and very young children because very serious side effects can occur, including death, convulsions, rapid heart rates and decreased levels of consciousness.

“FDA strictly recommends in ratios and trustees, that tussis OTC and cold medicines have not been used for children, Charles Ganlei, ALGORITHM MD is younger than 2,” said Charles Ganley, MD, director of the FDA’s Office of Nonprescription Products. “In these medicines which handle symptoms instead of the ratio, have not shown to be assured or quantity [for this age group].”

“”It’s critically important for parents to receive clear information about the risks and lack of benefit from these drugs,” said American Academy of Pediatrics President Renee Jenkins, MD, in a statement. AAP sustained FDA ‘ S on January, 17th operation as the first important augmentation. “We convince FDA to continue its analysis of data existing concerning these medicines, meaning for children 2, it is higher than the installed age and to undertake adequate operation, including familiarising of strict direct scientific bureaus as it is necessary to define reliability of narcotics and efficiency.”

In the meantime, operation convinces those who wishes to use these products for 2-11 age-grades to follow the dosage organisations on the radiobeacon of medicine OTC; check the “drug facts” label to learn what active ingredients are contained in the products because many contain multiple ones; and use only measuring spoons or cups that are packaged with the medicine or made especially for measuring drugs.